Cancer Research AACR Membership Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bendre, M. S.
Right arrow Articles by Suva, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bendre, M. S.
Right arrow Articles by Suva, L. J.
[Cancer Research 62, 5571-5579, October 1, 2002]
© 2002 American Association for Cancer Research

Tumor Biology

Expression of Interleukin 8 and not Parathyroid Hormone-related Protein by Human Breast Cancer Cells Correlates with Bone Metastasis in Vivo1

Manali S. Bendre, Dana Gaddy-Kurten, Thetsu Mon-Foote, Nisreen S. Akel, Robert A. Skinner, Richard W. Nicholas and Larry J. Suva2

Center for Orthopaedic Research, Departments of Orthopaedic Surgery and Physiology and Biophysics, Barton Research Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

Metastasis is the process by which tumor cells spread from their site of origin to distant sites after gaining access to the circulatory system. An understanding of the factors contributing to the metastatic potential of breast cancer cells to bone will enhance the prospect of developing new therapies that impede metastasis. In this study, we have used an in vivo selection scheme involving left cardiac ventricle injection into nude mice to identify a highly metastatic human breast cancer cell line (MDA-MET) from a less metastatic (MDA-231) parental cell line. In this model, tumor-bearing mice exhibit features similar to those associated with human metastatic bone disease such as osteolytic bone destruction. After inoculation, MDA-MET cells form devastating lesions within 4 weeks, whereas the parental cells do not, even after 10 weeks. In vitro, the MDA-MET cells have a similar growth rate to the parental MDA-231 cells yet demonstrate distinct adhesive and invasive phenotypes. MDA-MET cells show increased early adhesion to type IV collagen and are significantly more invasive through Matrigel than MDA-231 cells. Analysis of the gene expression profile in the metastatic MDA-MET versus poorly metastatic MDA-231 cells identified relatively few genes whose expression was altered >2-fold. Of particular interest was the lack of parathyroid hormone-related protein (PTHrP) mRNA expression, which was supported at the protein level by immunoradiometric assay. These data support the idea that PTHrP is not predictive of the metastasis of human breast cancer to bone. Another important difference between the two cell lines was the elevated expression by MDA-MET cells of the cytokine IL-8. Reverse transcriptase-PCR and ELISA confirmed the increased expression of IL-8 in MDA-MET cells. In addition, IL-8 mRNA expression is also elevated in a variety of human cancer cell lines with different metastatic potential in vivo. These experiments suggest that the elevated expression of IL-8 (and not PTHrP) by MDA-MET cells is a phenotypic change that may be related to their enhanced ability to metastasize to the skeleton.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. Purushothaman, L. Chen, Y. Yang, and R. D. Sanderson
Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
J. Biol. Chem., November 21, 2008; 283(47): 32628 - 32636.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Kominsky, S. M. Abdelmagid, M. Doucet, K. Brady, and K. L. Weber
Macrophage Inflammatory Protein-1{delta}: A Novel Osteoclast Stimulating Factor Secreted by Renal Cell Carcinoma Bone Metastasis
Cancer Res., March 1, 2008; 68(5): 1261 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. R. Amura, K. S. Brodsky, B. Gitomer, K. McFann, G. Lazennec, M. T. Nichols, A. Jani, R. W. Schrier, and R. Brian Doctor
CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation
Am J Physiol Cell Physiol, March 1, 2008; 294(3): C786 - C796.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. J. Suva, E. Hartman, J. D. Dilley, S. Russell, N. S. Akel, R. A. Skinner, W. R. Hogue, U. Budde, K. I. Varughese, T. Kanaji, et al.
Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease
Am. J. Pathol., February 1, 2008; 172(2): 430 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
I. Bieche, C. Chavey, C. Andrieu, M. Busson, S. Vacher, L. Le Corre, J.-M. Guinebretiere, S. Burlinchon, R. Lidereau, and G. Lazennec
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Endocr. Relat. Cancer, December 1, 2007; 14(4): 1039 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Le Gall, A. Bellahcene, E. Bonnelye, J. A. Gasser, V. Castronovo, J. Green, J. Zimmermann, and P. Clezardin
A Cathepsin K Inhibitor Reduces Breast Cancer Induced Osteolysis and Skeletal Tumor Burden
Cancer Res., October 15, 2007; 67(20): 9894 - 9902.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C. F. MacManus, J. Pettigrew, A. Seaton, C. Wilson, P. J. Maxwell, S. Berlingeri, C. Purcell, M. McGurk, P. G. Johnston, and D. J.J. Waugh
Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells
Mol. Cancer Res., July 1, 2007; 5(7): 737 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Zhao, R. Bachelier, I. Treilleux, P. Pujuguet, O. Peyruchaud, R. Baron, P. Clement-Lacroix, and P. Clezardin
Tumor {alpha}v{beta}3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Cancer Res., June 15, 2007; 67(12): 5821 - 5830.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Yang, V. MacLeod, H.-Q. Miao, A. Theus, F. Zhan, J. D. Shaughnessy Jr., J. Sawyer, J.-P. Li, E. Zcharia, I. Vlodavsky, et al.
Heparanase Enhances Syndecan-1 Shedding: A NOVEL MECHANISM FOR STIMULATION OF TUMOR GROWTH AND METASTASIS
J. Biol. Chem., May 4, 2007; 282(18): 13326 - 13333.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
A. S. Shanbhag, A. M. Kaufman, K. Hayata, and H. E. Rubash
Assessing Osteolysis with Use of High-Throughput Protein Chips
J. Bone Joint Surg. Am., May 1, 2007; 89(5): 1081 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Schwaninger, C. A. Rentsch, A. Wetterwald, G. van der Horst, R. L. van Bezooijen, G. van der Pluijm, C. W.G.M. Lowik, K. Ackermann, W. Pyerin, F. C. Hamdy, et al.
Lack of Noggin Expression by Cancer Cells Is a Determinant of the Osteoblast Response in Bone Metastases
Am. J. Pathol., January 1, 2007; 170(1): 160 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. A. Mohamedali, A. T. Poblenz, C. R. Sikes, N. M. Navone, P. E. Thorpe, B. G. Darnay, and M. G. Rosenblum
Inhibition of Prostate Tumor Growth and Bone Remodeling by the Vascular Targeting Agent VEGF121/rGel.
Cancer Res., November 15, 2006; 66(22): 10919 - 10928.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. G. Marguiles, V. S. Klimberg, S. Bhattacharrya, D. Gaddy, and L. J. Suva
Genomics and Proteomics of Bone Cancer.
Clin. Cancer Res., October 15, 2006; 12(20): 6217s - 6221s.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Boucharaba, C.-M. Serre, J. Guglielmi, J.-C. Bordet, P. Clezardin, and O. Peyruchaud
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
PNAS, June 20, 2006; 103(25): 9643 - 9648.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. L. Kominsky and N. E. Davidson
A "Bone" Fide Predictor of Metastasis? Predicting Breast Cancer Metastasis to Bone
J. Clin. Oncol., May 20, 2006; 24(15): 2227 - 2229.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Henderson, J. A. Danks, J. L. Slavin, G. B. Byrnes, P. F.M. Choong, J. B. Spillane, J. L. Hopper, and T. J. Martin
Parathyroid Hormone-Related Protein Localization in Breast Cancers Predict Improved Prognosis
Cancer Res., February 15, 2006; 66(4): 2250 - 2256.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. S. Bendre, A. G. Margulies, B. Walser, N. S. Akel, S. Bhattacharrya, R. A. Skinner, F. Swain, V. Ramani, K. S. Mohammad, L. L. Wessner, et al.
Tumor-Derived Interleukin-8 Stimulates Osteolysis Independent of the Receptor Activator of Nuclear Factor-{kappa}B Ligand Pathway
Cancer Res., December 1, 2005; 65(23): 11001 - 11009.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-W. Kim, M. Hayashi, J.-F. Lo, C. Fearns, R. Xiang, G. Lazennec, Y. Yang, and J.-D. Lee
Tid1 Negatively Regulates the Migratory Potential of Cancer Cells by Inhibiting the Production of Interleukin-8
Cancer Res., October 1, 2005; 65(19): 8784 - 8791.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W.-P. Lee, D.-I. Tai, K.-H. Lan, A. F.-Y. Li, H.-C. Hsu, E.-J. Lin, Y.-P. Lin, M.-L. Sheu, C.-P. Li, F.-Y. Chang, et al.
The -251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population
Clin. Cancer Res., September 15, 2005; 11(18): 6431 - 6441.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
G A Clines and T A Guise
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson
Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
Cancer Res., July 1, 2005; 65(13): 5778 - 5784.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. T. Price, J. M.W. Quinn, N. A. Sims, J. Vieusseux, K. Waldeck, S. E. Docherty, D. Myers, A. Nakamura, M. C. Waltham, M. T. Gillespie, et al.
The Heat Shock Protein 90 Inhibitor, 17-Allylamino-17-demethoxygeldanamycin, Enhances Osteoclast Formation and Potentiates Bone Metastasis of a Human Breast Cancer Cell Line
Cancer Res., June 1, 2005; 65(11): 4929 - 4938.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. J. Sweeney, S. Mehrotra, M. R. Sadaria, S. Kumar, N. H. Shortle, Y. Roman, C. Sheridan, R. A. Campbell, D. J. Murry, S. Badve, et al.
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer
Mol. Cancer Ther., June 1, 2005; 4(6): 1004 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
T. A. Guise
Thromboembolism to Metastasis: The Platelet-Lysophosphatidic Acid Connection
IBMS BoneKEy, March 1, 2005; 2(3): 12 - 16.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P. B. Vermeulen, and L. Y. Dirix
Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival
Clin. Cancer Res., November 1, 2004; 10(21): 7157 - 7162.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. L. Barnes, K. E. Hebert, M. Kamal, A. Javed, T. A. Einhorn, J. B. Lian, G. S. Stein, and L. C. Gerstenfeld
Fidelity of Runx2 Activity in Breast Cancer Cells Is Required for the Generation of Metastases-Associated Osteolytic Disease
Cancer Res., July 1, 2004; 64(13): 4506 - 4513.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. S. Doubrovina, M. M. Doubrovin, E. Vider, R. B. Sisson, R. J. O'Reilly, B. Dupont, and Y. M. Vyas
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
J. Immunol., December 15, 2003; 171(12): 6891 - 6899.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Kumar, H. Kishimoto, H. L. Chua, S. Badve, K. D. Miller, R. M. Bigsby, and H. Nakshatri
Interleukin-1{alpha} Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer
Am. J. Pathol., December 1, 2003; 163(6): 2531 - 2541.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Yoshioka, V. Foletta, O. Bernard, and K. Itoh
A role for LIM kinase in cancer invasion
PNAS, June 10, 2003; 100(12): 7247 - 7252.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.